SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-37208"
 

Search: onr:"swepub:oai:DiVA.org:umu-37208" > Cross-linked hyalur...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Cross-linked hyaluronan used as augmentation substance for treatment of glottal insufficiency : safety aspects and vocal fold function

Hertegård, Stellan (author)
Karolinska Institutet
Hallén, Lars (author)
Department of Otorhinolaryngology, Central Hospital, Falun, Sweden
Laurent, Claude (author)
Umeå universitet,Öron- näs- och halssjukdomar
show more...
Lindström, Elisabeth (author)
Karolinska Institutet
Olofsson, Katarina (author)
Umeå universitet,Öron- näs- och halssjukdomar
Testad, Per (author)
Department of Speech Pathology, Central Hospital, Falun, Sweden
Dahlqvist, Åke (author)
Umeå universitet,Öron- näs- och halssjukdomar
show less...
 (creator_code:org_t)
Wiley, 2002
2002
English.
In: The Laryngoscope. - : Wiley. - 0023-852X .- 1531-4995. ; 112:12, s. 2211-2219
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: To examine safety aspects and vocal fold function after vocal fold augmentation with a cross-linked hyaluronan derivative (hylan B gel) as compared with bovine collagen. STUDY DESIGN; A prospective, randomized trial. METHODS: Eighty-three patients with glottal insufficiency were treated with injection augmentation with hylan B gel and bovine collagen and were examined at 1, 6, and 12 months after treatment. Seventy patients with unilateral vocal fold paresis (n = 35) or atrophy (n = 35) were randomly assigned to receive either hylan B gel (n = 47) or collagen (n = 23) injections into one vocal fold. Thirteen patients with glottal insufficiency caused by scar defects or paresis resulting from malignant disease were included in a nonrandomized group and were treated only with hylan B gel. Evaluations were made from patients' subjective ratings (visual analogue scales), digitized videostroboscopic measurements, phonetograms, maximum phonation time, and phonation quotients. RESULTS: Twelve months after injections, the patients' self-ratings were significantly improved for both the hylan B gel and the collagen groups. In addition, the videostroboscopic measurements showed significantly improved glottal closure for both groups. However, for the hylan B gel group, vibration amplitude and glottal area variations were preserved, and this group showed significantly less resorption at the injected vocal fold edge. Furthermore, maximum phonation time had increased significantly for the hylan B gel patients (collagen, nonsignificant). No serious adverse events were observed; three patients injected with hylan B gel had temporary inflammation at the injection site, which resolved without sequelae. CONCLUSIONS: The results showed that both hylan B gel and collagen can be safely used for injection treatment of glottal insufficiency. Both treatments resulted in significantly improved voice as rated by the patients. However, the patients treated with hylan B gel showed better vocal fold status and longer maximum phonation time at 12 months after treatment as compared with patients treated with collagen.

Keyword

Hyaluronan
collagen
augmentation
injection
glottal insufficiency

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view